Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

被引:0
|
作者
Abdul Miah
Gabriel Tinoco
Songzhu Zhao
Lai Wei
Andrew Johns
Sandip Patel
Mingjia Li
Madison Grogan
Gabrielle Lopez
Marium Husain
Rebecca Hoyd
Khalid Mumtaz
Alexa Meara
Erin M. Bertino
Kari Kendra
Daniel Spakowicz
Gregory A. Otterson
Carolyn J. Presley
Dwight H. Owen
机构
[1] The Ohio State University Comprehensive Cancer Center,Division of Medical Oncology, Department of Internal Medicine
[2] The Ohio State University Comprehensive Cancer Center,Department of Biomedical Informatics and Center for Biostatistics
[3] The Ohio State University,Division of Gastroenterology Hepatology and Nutrition
[4] The Ohio State University Comprehensive Cancer Center,Division of Rheumatology and Immunology, Department of Internal Medicine
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Immunotherapy; Immune checkpoint inhibitor (ICI); Hepatitis; Liver injury; Hepatotoxicity; Immune-related adverse event (irAE);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2235 / 2242
页数:7
相关论文
共 50 条
  • [41] A Case of Immune Checkpoint Inhibitor-Induced Duodenitis
    Au, Sandra
    Chen, Wei
    Vance, Iris
    Wegermann, Kara
    ACG CASE REPORTS JOURNAL, 2024, 11 (10)
  • [42] Insights into immune checkpoint inhibitor-induced thyroiditis
    Melissa G. Lechner
    Mabel Ryder
    Nature Reviews Endocrinology, 2021, 17 : 643 - 644
  • [43] IMMUNE CHECKPOINT INHIBITOR-INDUCED NONINFLAMMATORY CARDIOMYOPATHY
    Parikh, Shrujal
    Nair, Ambica
    Cheriyath, Pramil
    Desai, Dhaval
    Okere, Arthur
    CHEST, 2024, 166 (04) : 846A - 847A
  • [44] Immune Checkpoint Inhibitor-induced Bilateral Vestibulopathy
    Koch, Elias A. T.
    Nickel, Florian T.
    Heinzerling, Lucie
    Schulz, Yvonne K.
    Berking, Carola
    Erdmann, Michael
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (03) : 114 - 117
  • [45] Identification of Immune Checkpoint Inhibitor-Induced Diabetes
    Ruiz-Esteves, Karina N.
    Shank, Kaitlyn R.
    Deutsch, Aaron J.
    Gunturi, Alekhya
    Chamorro-Pareja, Natalia
    Colling, Caitlin A.
    Zubiri, Leyre
    Perlman, Katherine
    Ouyang, Tianqi
    Villani, Alexandra-Chloe
    Florez, Jose C.
    Gusev, Alexander
    Reynolds, Kerry L.
    Miller, Karen K.
    Udler, Miriam S.
    Sise, Meghan E.
    Rengarajan, Michelle
    JAMA ONCOLOGY, 2024, 10 (10) : 1409 - 1416
  • [46] Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
    Jimenez-Alejandre, Rosa
    Ruiz-Fernandez, Ignacio
    Martin, Pilar
    CANCERS, 2022, 14 (18)
  • [47] Immune checkpoint inhibitor-induced musculoskeletal manifestations
    Angelopoulou, Foteini
    Bogdanos, Dimitrios
    Dimitroulas, Theodoros
    Sakkas, Lazaros
    Daoussis, Dimitrios
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (01) : 33 - 42
  • [48] Immune checkpoint inhibitor-induced musculoskeletal manifestations
    Foteini Angelopoulou
    Dimitrios Bogdanos
    Theodoros Dimitroulas
    Lazaros Sakkas
    Dimitrios Daoussis
    Rheumatology International, 2021, 41 : 33 - 42
  • [49] Immune Checkpoint Inhibitor-induced Sicca Syndrome
    Bitoun, Samuel
    Rousseau, Antoine
    Gosset, Marjolaine
    Belkhir, Rakiba
    Lazure, Thierry
    Mariette, Xavier
    Nocturne, Gaetane
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2024, 50 (02) : 291 - 300
  • [50] A CASE OF IMMUNE CHECKPOINT INHIBITOR-INDUCED PNEUMONITIS
    Triplett, David
    Gannamraj, Krishna
    CHEST, 2021, 160 (04) : 1683A - 1683A